Contemporary management of infected necrosis complicating severe acute pancreatitis

[1]  B. Ammori,et al.  Clinical laboratory assessment of acute pancreatitis. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[2]  A. Leppäniemi,et al.  Recent advances in the surgical management of necrotizing pancreatitis , 2005, Current opinion in critical care.

[3]  A. Siriwardena,et al.  Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis , 2005, Critical care.

[4]  J. Decruyenaere,et al.  Intra-abdominal hypertension in patients with severe acute pancreatitis , 2005, Critical care.

[5]  M. Astiz,et al.  Acute pancreatitis: a possible role for activated protein C? , 2005, Critical care.

[6]  A. Işık,et al.  Correction: The effect of activated protein C on experimental acute necrotizing pancreatitis , 2005, Critical Care.

[7]  A. Işık,et al.  The effect of activated protein C on experimental acute necrotizing pancreatitis , 2005, Critical care.

[8]  H. Gerlach.  Risk management in patients with severe acute pancreatitis , 2004, Critical care.

[9]  C. McKay,et al.  The continuing challenge of early mortality in acute pancreatitis , 2004, The British journal of surgery.

[10]  Jing-xia Zhang,et al.  Clinical characteristics and management of patients with early acute severe pancreatitis: experience from a medical center in China. , 2004, World journal of gastroenterology.

[11]  B. Ammori,et al.  The Early Increase in Intestinal Permeability and Systemic Endotoxin Exposure in Patients with Severe Acute Pancreatitis Is Not Associated with Systemic Bacterial Translocation: Molecular Investigation of Microbial DNA in the Blood , 2003, Pancreas.

[12]  A. Siriwardena,et al.  Intravenous n‐acetylcysteine, ascorbic acid and selenium‐based anti‐oxidant therapy in severe acute pancreatitis , 2003, Scandinavian journal of gastroenterology.

[13]  A. Siriwardena,et al.  Outcome of Necrosectomy in Acute Pancreatitis: the Case for Continued Vigilance , 2002, Scandinavian journal of gastroenterology.

[14]  S. Ashley,et al.  Necrotizing Pancreatitis: Contemporary Analysis of 99 Consecutive Cases , 2001, Annals of surgery.

[15]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[16]  C. McKay,et al.  Percutaneous Necrosectomy and Sinus Tract Endoscopy in the Management of Infected Pancreatic Necrosis: An Initial Experience , 2000, Annals of surgery.

[17]  S. Kriwanek,et al.  Early versus late necrosectomy in severe necrotizing pancreatitis. , 1998, American journal of surgery.

[18]  C. Imrie,et al.  Pancreatic necrosis: Assessment of outcome related to quality of life and cost of management , 1993, The British journal of surgery.

[19]  M. Büchler,et al.  Bacterial contamination of pancreatic necrosis. A prospective clinical study. , 1986, Gastroenterology.

[20]  P. Laterre,et al.  Intraabdominal hypertension in patients with severe acute pancreatitis: An interim analysis of a prospective, multicenter study , 2007 .

[21]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .